AURA: Aura Biosciences Inc Kompaniya qiymatining sof foydaga nisbati

Aura Biosciences Inc - AURA emitenti grafik logotipi

Aura Biosciences, Inc. (AURA) mustahkam patent portfeli bilan qo'llab-quvvatlanadigan, ko'z o'smiralari uchun innovatsion maqsadli terapiyani ishlab chiqmoqda va kompaniyaning -5.40 qiymatidagi narx harakati quyida tasvirlangan. Biznes onkologiya markazlari orqali global qamrovga tayanadi, bu esa marketing xarajatlarini minimallashtiradi. Klinik sinovlarning barqarorligi noyob komponentlar yetkazib berish ustidan qat'iy nazorat va logistika zanjirlarini diversifikatsiya qilish orqali ta'minlanadi.

Narx-foyda koeffitsiyenti: Aura Biosciences, Inc. (AURA) 14.08.2022 - 18.11.2026 uchun

Aura Biosciences Inc (AURA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning jamlanma tahlili:AURA, Aura Bio
Aura Biosciences yetakchi tovari

Uzoq muddatli investitsiyalar biznesning haqiqiy foydasi nisbatda bozor premiumlarini qat'iy nazorat qilishni talab qiladi. Aura Biosciences, Inc. (AURA) barqarorligi biomeditsinaning gumanitar maqomi bilan qo'llab-quvvatlanadi, bu esa baholash jarayonida geosiyosiy risklarni minimallashtiradi. Kompaniyaning fundamental P/E ko'rsatkichi joriy aksiya narxini sof foyda bilan solishtirib, bozorning kelajakdagi o'sish uchun to'lov qilishga tayyorligini o'lchaydi. Ko'rsatkichlarning past qiymatlari aktivning qadrsizlanganligidan dalolat beradi, garchi ular pul oqimini shakllantirishdagi muammolarni ko'rsatishi mumkin bo'lsa-da.

Raqobatdosh kompaniyalar

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori CADL|P/E multiplikatori Accuray (ARAY)|Narxning foydaga nisbati SELLAS Life Sciences Group Inc. SLS|ACTU - Narx-foyda koeffitsiyenti|CTOR: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Fate Therapeutics Corp (FATE)|Narx-foyda koeffitsiyenti WHWK|Narx-foyda multiplikatori TCRX (TScan Therapeutics, Inc.)|P/E multiplikatori CSBR|XBIT - Kapitalizatsiyaning foydaga nisbati|CEL-SCI Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OSTX|radiopharmtheranostics.com - P/E multiplikatori|ARTV: Narxning foydaga nisbati|ANL (adlainortye.com) - Narx-foyda koeffitsiyenti|VERU - Biznesning o‘zini qoplash muddati|TPST (Tempest Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori xiliotx.com|Narxning foydaga nisbati Enochian BioSciences (RENB)|Narxning foydaga nisbati MURA (Mural Oncology PLC)|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV